This randomised clinical trial will determine whether an infusion of sodium bicarbonate diluted in 5% dextrose, compared with an infusion of 5% dextrose alone, reduces 30-day Major Adverse Kidney Events for patients with metabolic acidosis and vasopressor dependency.